PT  - JOURNAL ARTICLE
AU  - Griette, Q.
AU  - Demongeot, J.
AU  - Magal, P.
TI  - A robust phenomenological approach to investigate COVID-19 data for France
AID  - 10.1101/2021.02.10.21251500
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.10.21251500
4099  - http://medrxiv.org/content/early/2021/02/12/2021.02.10.21251500.short
4100  - http://medrxiv.org/content/early/2021/02/12/2021.02.10.21251500.full
AB  - We provide a new method to analyze the COVID-19 cumulative reported cases data based on a two-step process: first we regularize the data by using a phenomenological model which takes into account the endemic or epidemic nature of the time period, then we use a mathematical model which reproduces the epidemic exactly. This allows us to derive new information on the epidemic parameters and to compute the effective basic reproductive ratio on a daily basis. Our method has the advantage of identifying robust trends in the number of new infectious cases and produces an extremely smooth reconstruction of the epidemic. The number of parameters required by the method is parsimonious: for the French epidemic between February 2020 and January 2021 we use only 11 parameters in total.Competing Interest StatementThe authors have declared no competing interest.Funding Statementhis research was also funded by the Agence Nationale de la Recherche in France (Project name : MPCUII (QG, PM)).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We do not have anything to do with IRB/oversight body I comfirm the ethical guidelines have been followedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data were produced